BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Quercetin
,
rs7903146
,
IL1A
,
Coagulation
,
Allergy to pollen
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
DNA mismatch repair protein Mlh1
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Cecum
Transverse colon
Rectum colon
Ascending colon
Sigmoid colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Injury of eye region
Metabolic syndrome X
Traumatic injury
Cirrhosis of liver
Hepatic fibrosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
tetrachloroisophthalonitrile
Gramicidin
5-azacytosine
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one
Nickel
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-34a-5p
C9orf72
FANCL
MAST2
CASP4
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
OMIM - Cancer
Cancer Gene Census - mutations in cancer genes
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
OMIM - Neoplasm of sebaceous gland
Multiple cancer cell lines treated with 32 kinase inhibitors
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for DNA mismatch repair protein Mlh1
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Canc…
Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid C…
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA M…
Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatc…
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent En…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ